Literature DB >> 18513156

Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006.

Laura K Certain1, Marnie Briceño, Steven M Kiara, Alexis M Nzila, William M Watkins, Carol Hopkins Sibley.   

Abstract

Resistance to the antimalarial drug sulfadoxine-pyrimethamine (SP) emerged in Plasmodium falciparum from Asia in the 1960s and subsequently spread to Africa. It is not known whether alleles that confer SP resistance also arose independently in Africa. We defined the coding region and microsatellite haplotypes of dhfr alleles in P. falciparum collected in Kilifi, Kenya, during 1987--2006, which spans the period when SP was first introduced. Isolates that carried a double-mutant or triple-mutant dhfr allele were detected at a low frequency, even during 1987--1988. Each of 2 double mutants carried a unique haplotype, and both were related to wild-type haplotypes from the same population. The number of isolates that carried a triple-mutant dhfr allele increased rapidly after introduction of SP and shared the haplotype of the triple mutant derived form Asia. We observed no triple-mutant alleles with haplotypes related to those of the Africa-derived wild-type and double-mutant alleles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18513156      PMCID: PMC2680814          DOI: 10.1086/588198

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

1.  Averting a malaria disaster.

Authors:  N J White; F Nosten; S Looareesuwan; W M Watkins; K Marsh; R W Snow; G Kokwaro; J Ouma; T T Hien; M E Molyneux; T E Taylor; C I Newbold; T K Ruebush; M Danis; B M Greenwood; R M Anderson; P Olliaro
Journal:  Lancet       Date:  1999-06-05       Impact factor: 79.321

2.  Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.

Authors:  James G Kublin; Fraction K Dzinjalamala; Deborah D Kamwendo; Elissa M Malkin; Joseph F Cortese; Lisa M Martino; Rabia A G Mukadam; Stephen J Rogerson; Andres G Lescano; Malcolm E Molyneux; Peter A Winstanley; Phillips Chimpeni; Terrie E Taylor; Christopher V Plowe
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

3.  Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles.

Authors:  Andrea M McCollum; Amanda C Poe; Mary Hamel; Curtis Huber; Zhiyong Zhou; Ya Ping Shi; Peter Ouma; John Vulule; Peter Bloland; Laurence Slutsker; John W Barnwell; Venkatachalam Udhayakumar; Ananias A Escalante
Journal:  J Infect Dis       Date:  2006-06-13       Impact factor: 5.226

4.  Plasmodium falciparum: a novel method for analyzing haplotypes in mixed infections.

Authors:  Laura K Certain; Carol H Sibley
Journal:  Exp Parasitol       Date:  2006-10-17       Impact factor: 2.011

Review 5.  Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?

Authors:  C H Sibley; J E Hyde; P F Sims; C V Plowe; J G Kublin; E K Mberu; A F Cowman; P A Winstanley; W M Watkins; A M Nzila
Journal:  Trends Parasitol       Date:  2001-12

6.  Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion.

Authors:  M T Duraisingh; J Curtis; D C Warhurst
Journal:  Exp Parasitol       Date:  1998-05       Impact factor: 2.011

7.  Mutation rates in the dihydrofolate reductase gene of Plasmodium falciparum.

Authors:  S Paget-McNicol; A Saul
Journal:  Parasitology       Date:  2001-05       Impact factor: 3.234

8.  Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.

Authors:  E Amukoye; P A Winstanley; W M Watkins; R W Snow; J Hatcher; M Mosobo; E Ngumbao; B Lowe; M Ton; G Minyiri; K Marsh
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

9.  The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya.

Authors:  E K Mberu; M K Mosobo; A M Nzila; G O Kokwaro; C H Sibley; W M Watkins
Journal:  Am J Trop Med Hyg       Date:  2000-03       Impact factor: 2.345

10.  Relationships between Plasmodium falciparum transmission by vector populations and the incidence of severe disease at nine sites on the Kenyan coast.

Authors:  C N Mbogo; R W Snow; C P Khamala; E W Kabiru; J H Ouma; J I Githure; K Marsh; J C Beier
Journal:  Am J Trop Med Hyg       Date:  1995-03       Impact factor: 2.345

View more
  24 in total

1.  Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.

Authors:  Md Tauqeer Alam; Dziedzom K de Souza; Sumiti Vinayak; Sean M Griffing; Amanda C Poe; Nancy O Duah; Anita Ghansah; Kwame Asamoa; Laurence Slutsker; Michael D Wilson; John W Barnwell; Venkatachalam Udhayakumar; Kwadwo A Koram
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

2.  Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay and molecular analysis.

Authors:  Hoseah M Akala; Fredrick L Eyase; Agnes C Cheruiyot; Angela A Omondi; Bernhards R Ogutu; Norman C Waters; Jacob D Johnson; Mark E Polhemus; David C Schnabel; Douglas S Walsh
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

Review 3.  Drug-resistant malaria in Sudan: A review of evidence and scenarios for the future.

Authors:  Ahmed Awad Adeel
Journal:  Sudan J Paediatr       Date:  2012

Review 4.  Monitoring antimalarial drug resistance: Applying lessons learned from the past in a fast-moving present.

Authors:  Carol Hopkins Sibley; Ric N Price
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-04-20       Impact factor: 4.077

5.  Induction of antimalaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistance.

Authors:  Johannes Friesen; Steffen Borrmann; Kai Matuschewski
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

6.  Characteristics of genetic hitchhiking around dihydrofolate reductase gene associated with pyrimethamine resistance in Plasmodium falciparum isolates from India.

Authors:  Vanshika Lumb; Manoj K Das; Neeru Singh; Vas Dev; Yagya D Sharma
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

7.  Origin and evolution of sulfadoxine resistant Plasmodium falciparum.

Authors:  Sumiti Vinayak; Md Tauqeer Alam; Tonya Mixson-Hayden; Andrea M McCollum; Rithy Sem; Naman K Shah; Pharath Lim; Sinuon Muth; William O Rogers; Thierry Fandeur; John W Barnwell; Ananias A Escalante; Chansuda Wongsrichanalai; Frederick Ariey; Steven R Meshnick; Venkatachalam Udhayakumar
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

8.  Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine.

Authors:  Allen L Malisa; Richard J Pearce; Salim Abdulla; Hassan Mshinda; Patrick S Kachur; Peter Bloland; Cally Roper
Journal:  Malar J       Date:  2010-07-05       Impact factor: 2.979

9.  Comparative transcriptional and genomic analysis of Plasmodium falciparum field isolates.

Authors:  Margaret J Mackinnon; Jinguang Li; Sachel Mok; Moses M Kortok; Kevin Marsh; Peter R Preiser; Zbynek Bozdech
Journal:  PLoS Pathog       Date:  2009-10-30       Impact factor: 6.823

Review 10.  Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria.

Authors:  Paul D Roepe
Journal:  Future Microbiol       Date:  2009-05       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.